Pregnant women with Crohn's disease and rheumatoid arthritis can use Anti-tumor necrosis factor medications (anti-TNFs), as they help prevent chronic inflammatory diseases.
New Treatment Route for Inflammatory Rheumatism is Now Open
The absence of anti-inflammatory protein A20 leads to a significant increase in a signalling molecule STAT1, which promotes the development of enthesitis.
The absence of anti-inflammatory protein A20 leads to a significant increase in a signalling molecule STAT1, which promotes the development of enthesitis.
‘Using Anti-tumor necrosis factor medications (anti-TNFs) during pregnancy can be safe for women with Crohn's Disease and rheumatoid arthritis.’
These findings are reassuring for women of childbearing age affected by chronic inflammatory diseases considering treatment with CZP who wish to become or are pregnant. "In this large study of pregnancies, it appears that taking CZP during pregnancy did not increase the chances for pregnancy loss, preterm birth, or birth defects," said lead author Dr. Megan Clowse, of Duke University Medical Center.
"Continuing anti-TNFs in pregnancy has been recommended for many years for women with Crohn's Disease, and these data suggest that it is also safe for women with other inflammatory conditions, such as rheumatoid arthritis."
AIDS Health Center Units To Offer Penicillin Shots For Rheumatic Heart Disease
Linking rheumatic heart disease services into existing HIV/AIDS clinics and primary health care centers can reduce the death rate of RHD.
Linking rheumatic heart disease services into existing HIV/AIDS clinics and primary health care centers can reduce the death rate of RHD.
Source-Eurekalert
Scorpion Venom Reduces Severity of Rheumatoid Arthritis
Scorpion venom has compounds that block potassium channels and this property is used to reduce inflammation and pain in special cells that aggravate rheumatoid arthritis.
Scorpion venom has compounds that block potassium channels and this property is used to reduce inflammation and pain in special cells that aggravate rheumatoid arthritis.
Biologics Do Not Increase The Risk of Second Malignancy
The concern for second malignancy or cancer recurrences in patients with history of cancer diagnosis has led to some reluctance in treating arthritis patients.
The concern for second malignancy or cancer recurrences in patients with history of cancer diagnosis has led to some reluctance in treating arthritis patients.
